GH Axis Research
Peptides targeting the somatotropic axis — GHRHs, GHRPs, and IGF-1 analogs for growth hormone pathway research.
The growth hormone axis governs pituitary GH secretion and its downstream effector IGF-1. Key research compounds include CJC-1295 and Sermorelin — GHRH analogues that stimulate the anterior pituitary directly — and GHRP-6 and Ipamorelin, ghrelin-receptor agonists that trigger pulsatile GH release. IGF-1 LR3 is a recombinant, long-acting variant with a C-terminal extension studied for extended in vitro bioavailability, completing the GH axis research toolkit.
.png&w=3840&q=75&dpl=dpl_5JZXxUYT2pJGCJUqkETXbtXiAjF8)
CJC-1295 (No DAC)
Mol. Wt.
3,367.97 g/mol
Purity
≥98%
CAS No.
863288-34-0

Fragment 176-191
Mol. Wt.
1,815.12 g/mol
Purity
≥98%
CAS No.
66004-57-7

MGF (Mechano Growth Factor)
Mol. Wt.
2,867.16 g/mol
Purity
≥98%
CAS No.
162809-23-6
For in-vitro research use only. Not for human or veterinary use.










